drug targets
| 3 min read
Using an unbiased molecular screen, researchers found a new gene that could be targeted to treat fragile X syndrome.
| 5 min read
Researchers identify a slow-cycling, therapy-tolerant state in breast cancer cells linked to Rac1 signaling and late metastatic relapse.
| 3 min read
The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale
Available on Demand
Faster drug discovery depends on both speed and data quality — a new mass spectrometry technology is helping researchers achieve both.
| 3 min read
The drugmaker expands access to AI-driven discovery, but also positions its technology to become a standard across the sector.
| 6 min read
A domain-specific AI platform enables scientists to generate and test hypotheses faster, helping pharma teams reduce target prioritization timelines from weeks to days.
| 5 min read
From new biomarkers to smarter clinical trials, AI is transforming how cancer drugs are developed and how patients are diagnosed and treated.
| 2 min read
Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target development program
| 5 min read
Chemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.
| 8 min read
An understudied melanoma arises without sun exposure, but researchers are beginning to shed light on this challenging form of skin cancer.
